Clinical efficacy of donafenib combined with PD-1 inhibitor and vascular intervention therapy in the treatment of unresectable hepatocellular carcinoma
|更新时间:2025-11-10
|
Clinical efficacy of donafenib combined with PD-1 inhibitor and vascular intervention therapy in the treatment of unresectable hepatocellular carcinoma
“The latest research shows that the combination of donafenib with PD-1 inhibitors and vascular intervention therapy has significant efficacy and good safety in patients with unresectable hepatocellular carcinoma.”
SU Lan,ZHU Jinghan,LIU Mingming,et al.Clinical efficacy of donafenib combined with PD-1 inhibitor and vascular intervention therapy in the treatment of unresectable hepatocellular carcinoma[J].ZHONGGUO YAOFANG,2025,36(21):2692-2698.
SU Lan,ZHU Jinghan,LIU Mingming,et al.Clinical efficacy of donafenib combined with PD-1 inhibitor and vascular intervention therapy in the treatment of unresectable hepatocellular carcinoma[J].ZHONGGUO YAOFANG,2025,36(21):2692-2698. DOI: 10.6039/j.issn.1001-0408.2025.21.13.
Clinical efficacy of donafenib combined with PD-1 inhibitor and vascular intervention therapy in the treatment of unresectable hepatocellular carcinoma